Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein-Based Vaccine Adjuvanted With Glucopyranosyl Lipid A-Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria Challenge.
DeAnna J Friedman-KlabanoffAndrea A BerryMark A TravassosMallory ShriverCatherine CoxJessica ButtsJordan S LundeenKathleen A StraussSudhaunshu JoshiBiraj ShresthaAnnie X MoEffie Y H NomicosGregory A DeyeJason A RegulesElke S Bergmann-LeitnerMarcela F PasettiMatthew B LaurensPublished in: The Journal of infectious diseases (2024)
NCT03589794.